01/31/2025
3:15 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025
4:47 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
2:31 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
3:18 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
2:46 PM | GALAPAGOS NV (Subject)
Gilead Sciences (Filed by)
| Form SCHEDULE 13D/A | |
01/03/2025
5:33 PM | Berger Dietmar (Reporting)
Gilead Sciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/03/2025
5:38 PM | Berger Dietmar (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
7:17 PM | ASSEMBLY BIOSCIENCES, INC. (Subject)
Gilead Sciences (Filed by)
| Form SCHEDULE 13D/A | |
12/23/2024
7:26 PM | ASSEMBLY BIOSCIENCES, INC. (Issuer)
Gilead Sciences (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
3:15 PM | Gilead Sciences (Filed by)
Xilio Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G/A | |
12/19/2024
3:19 PM | Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for GILD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Gilead Sciences and its competitors with MarketBeat's FREE daily newsletter. |
12/17/2024
4:27 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:22 PM | Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:08 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024
6:48 PM | Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:51 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:24 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:05 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:08 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:13 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
1:43 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
7:10 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
1:35 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024
5:14 PM | Bluestone Jeffrey (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
3:15 PM | Gilead Sciences (Subject)
Parsey Merdad (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
6:31 PM | Bluestone Jeffrey (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2024
3:15 PM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:13 PM | Gilead Sciences (Subject)
| Form FWP | |
11/13/2024
8:02 AM | Gilead Sciences (Filer)
| Form 424B5 | |
11/06/2024
3:19 PM | Gilead Sciences (Subject)
Parsey Merdad (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
3:07 PM | Gilead Sciences (Subject)
Mercier Johanna (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
3:09 PM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
2:09 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
3:58 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
6:07 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:08 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:43 PM | Gilead Sciences (Subject)
Mercier Johanna (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:45 PM | Gilead Sciences (Subject)
Parsey Merdad (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
6:30 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
6:33 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
6:38 PM | Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Will DeepSeek pop the AI bubble? (Ad) An overseas AI rival sent shockwaves through the U.S. tech market last week...
Leaving millions of investors worrying – Is this the end of the great AI bull run? We've outlined the exact steps to take in a free interview. |
09/11/2024
6:41 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
6:20 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
6:23 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
2:23 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
1:23 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
4:17 PM | Gilead Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/26/2024
4:28 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
8:01 AM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2024
7:06 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
7:31 PM | ASSEMBLY BIOSCIENCES, INC. (Issuer)
Gilead Sciences (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
7:35 PM | ASSEMBLY BIOSCIENCES, INC. (Subject)
Gilead Sciences (Filed by)
| Form SC 13D/A | |
06/11/2024
6:12 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:15 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:18 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:20 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:23 PM | Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:25 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:57 PM | BARTON JACQUELINE K (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:16 PM | Gilead Sciences (Issuer)
MANWANI HARISH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:23 PM | Gilead Sciences (Issuer)
WELTERS ANTHONY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:26 PM | Gilead Sciences (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:30 PM | Gilead Sciences (Issuer)
LOVE TED W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:08 PM | Bluestone Jeffrey (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
8:29 PM | GALAPAGOS NV (Subject)
Gilead Sciences (Filed by)
| Form SC 13D/A | |
04/19/2024
3:31 PM | Gilead Sciences (Reporting)
LEAP THERAPEUTICS, INC. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/19/2024
3:31 PM | Gilead Sciences (Filed by)
LEAP THERAPEUTICS, INC. (Subject)
| Form SC 13G | |
04/05/2024
3:31 PM | Gilead Sciences (Filed by)
Xilio Therapeutics, Inc. (Subject)
| Form SC 13G | |
04/03/2024
5:48 PM | Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
5:50 PM | Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:38 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
4:19 PM | Gilead Sciences (Issuer)
Lofton Kevin E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:07 PM | Gilead Sciences (Filer)
| Form DEF 14A | |
03/28/2024
3:07 PM | Gilead Sciences (Filer)
| Form DEFA14A | |
03/22/2024
8:21 AM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
6:50 AM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/20/2024
3:12 PM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/15/2024
3:11 PM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/12/2024
3:19 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:11 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:14 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:59 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:03 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:34 AM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T/A | |
02/29/2024
5:35 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:49 PM | Gilead Sciences (Subject)
Parsey Merdad (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
3:38 PM | Gilead Sciences (Subject)
Parsey Merdad (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
5:09 AM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T | |
02/13/2024
4:48 PM | Gilead Sciences (Reporting)
Kyverna Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
7:37 AM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
7:39 AM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-C | |
Urgent Bitcoin alert for RIGHT NOW (Ad) Former billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 40-year career.
During the presentation, Larry reveals a strategy every trader and investor needs to understand.
He calls it “Bitcoin Skimming.” So please… click here to watch now. |
02/09/2024
5:21 PM | Capital World Investors (Filed by)
Gilead Sciences (Subject)
| Form SC 13G/A | |
02/07/2024
4:35 PM | Gilead Sciences (Reporting)
Kyverna Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2024
5:01 PM | Gilead Sciences (Issuer)
LOVE TED W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:20 PM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
1:42 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
1:34 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
1:19 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
1:11 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
12:40 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
